Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices 8737 

Rights, 200 Independence Ave. SW., 

Room 509F, Washington, DC 20201. 

NOTIFICATION PROCEDURE: 

Contact System Manager (above). 

Include name and address of 

complainant, and name of the recipient 

against which the allegation was filed. 

The Department is exempting all 

investigative records from this provision 

(see below: Records Exempted). 

RECORD ACCESS PROCEDURE: 

Same as notification procedures. 

Requesters should also reasonably 

specify the record contents being 

sought. Requests should be made to the 

system manager (above). The 

Department is exempting all 

investigative records from this provision 

(see below: Records Exempted). 

CONTESTING RECORD PROCEDURE: 

Contact the official(s) at the address 

specified under System Manager, and 

reasonably identify the record and 

specify the information to be contested 

and corrective action sought with 

supporting justification. (These 

procedures are in accordance with 

Department Regulations (45 CFR 5b.7) 

Federal Register, October 8, 1975, page 

47411.) The Department is exempting 

all investigative records from this 

provision (see below: Records 

Exempted). 

RECORD SOURCE CATEGORIES: 

Information is provided by 

complainants and covered entities. 

SYSTEM RECORDS EXEMPTED FROM CERTAIN

PROVISIONS OF THE ACT: 

OCR investigative records maintained 

in PIMS, either as paper records or 

electronic documents are records 

compiled for law enforcement purposes 

are exempt under subsection (k)(2) from 

the notification, access, correction and 

amendment provisions of the Privacy 

Act. 

APPENDIX NUMBER 1—SYSTEM LOCATIONS: 

This system is located at HHS offices 

in the following cities. 

Headquarters, PIMS Project Manager, 

Resource Management Division, 

Office for Civil Rights, 200 

Independence Ave., SW., Room 509F, 

Washington, DC 20201. 

Region I, Regional Manager, OCR/HHS, 

J.F. Kennedy Federal Building—Room 

1875 Boston, Massachusetts 02203. 

Region II, Regional Manager, OCR/HHS, 

26 Federal Plaza—Suite 3312, New 

York, NY 10278. 

Region III, Regional Manager, OCR/ 

HHS, 150 S. Independence Mall West, 

Suite 372, Public Ledger Building, 

Philadelphia, PA 19106. 

Region IV, Regional Manager, OCR/ 

HHS, Atlanta Federal Center, Suite 

3B70, 61 Forsyth Street, SW., Atlanta, 

GA 30303. 

Region V, Regional Manager, OCR/HHS, 

233 N. Michigan Ave, Suite 240, 

Chicago, IL 60601. 

Region VI, Regional Manager, OCR/ 

HHS, 1301 Young Street, Suite 1169, 

Dallas, TX 75202. 

Region VII, Regional Manager, OCR/ 

HHS, 601 E. 12th Street—Room 248, 

Kansas City, MO 64106. 

Region VIII, Regional Manager, OCR/ 

HHS, Federal Office Building, 1961 

Stout Street—Room 1185, Denver, CO 

80294. 

Region IX, Regional Manager, OCR/ 

HHS, 50 United Nations Plaza—Room 

322, San Francisco, CA 94102. 

Region X, Regional Manager, OCR/HHS, 

2201 Sixth Avenue—Suite 900, 

Seattle, WA 98121. 

[FR Doc. E7–3283 Filed 2–26–07; 8:45 am] 

BILLING CODE 4153–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–07–05CZ] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Joan Karr, CDC 

Acting Reports Clearance Officer, 1600 

Clifton Road, MS–D74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Assessing Diabetes Detection 

Initiative for Policy Decision—New—

National Center for Chronic Disease 

Prevention and Health Promotion 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

Type 2 diabetes is a chronic disease 

that affects more than 18 million 

Americans, approximately 5 million of 

whom do not know that they have the 

disease. As the disease progresses, it 

often causes severe complications, 

including heart disease, blindness, 

lower extremity arterial disease, and 

kidney failure. American Indians, 

African Americans, Latino Americans, 

and some Asian Americans and Pacific 

Islanders are disproportionately affected 

by diabetes. Identifying persons who 

have undiagnosed diabetes and treating 

them could prevent or delay diabetes 

complications. 

In November 2003 the Diabetes 

Detection Initiative (DDI) was launched 

in 10 locations around the U.S. to 

identify a portion of the estimated 5 

million people with undiagnosed Type 

2 diabetes, targeting specific areas in 

each of 10 locales in which residents are 

likely to be at higher risk for Type 2 

diabetes. Implementation of the DDI 

involved distributing a paper-and-pencil 

risk test. Individuals whose score 

indicated that they were at an increased 

risk for diabetes were advised to see 

their regular doctor (or to schedule an 

appointment at one of several clinics 

that had agreed to participate in the 

DDI), to receive a finger-stick or other 

tests to confirm whether or not they 

have diabetes. Whether or not the DDI 

should be expanded to other 

communities depends on the health 

benefits and costs of the program. The 

CDC is planning to conduct a study to 

provide this critical information. 

The planned study will assess the 

resources used, the cost per case 

detected, and the perceived benefit of 

the DDI to participants. Data for the 

economic assessment will be obtained 

by conducting three separate surveys: 

(1) A local implementation team survey 

will be administered to the 10 DDI local 

implementation leaders to obtain 

information on resources used by the 

members of DDI local implementation 

teams and community based 

organizations to implement the nonmedical service delivery activities for 

the DDI program; (2) a health clinic 


cprice-sewell on PROD1PC62 with NOTICES
8738 Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices 

leadership survey will be sent to the 

clinic directors in each of the 43 clinics 

that participated in the DDI across the 

10 locations to obtain information on 

the cost of delivering the medical 

services required in diabetes screening 

and diagnosis; and (3) a patient survey 

will be administered to a sample of 600 

patients at the 43 participating clinics to 

obtain information regarding patient 

out-of-pocket medical and non-medical 

direct health care costs and the 

perceived economic benefits of diabetes 

screening. The results of the study will 

also provide information needed for 

conducting a more complete costeffectiveness analysis of screening for 

undiagnosed diabetes. 

The local implementation team 

survey will be mailed to the local DDI 

implementation team leader in each of 

the 10 regions to collect information 

regarding the staff time and other 

resources used to implement the DDI 

program (including the staff time and 

resources used by community-based 

organizations that participated in the 

DDI implementation). These planning 

and implementation activities include 

participating in meetings and 

conference calls, recruiting clinics and 

community-based organizations to 

participate in the DDI, distributing risk 

tests, organizing health fairs and other 

community events, and designing media 

campaigns to promote the DDI. 

The health clinic leadership survey 

will be mailed to the clinic director at 

each of the 43 clinics across the 10 

locations that participated in the DDI 

implementation. The survey will collect 

information regarding the costs 

associated with the clinic’s participation 

in the DDI. These will include the 

medical costs of providing care to 

patients who visited the clinic as a 

result of the DDI, staff time associated 

with DDI planning and implementation, 

and any staff time that was devoted to 

performing finger stick tests at locations 

other than the health clinic (e.g., health 

fairs, shopping malls, work sites, 

housing complexes). Of the 43 clinics to 

be surveyed, we expect that 30 (70%) 

will complete the survey. 

A computer-assisted in-person patient 

survey will be administered to a sample 

of 600 clinic patients at the 43 clinics 

that participated in the DDI. The survey 

will collect background information, 

out-of-pocket medical and non-medical 

direct health care costs (e.g., copayments, transportation costs, value of 

patients’ time associated with the clinic 

visit), and preferred features of a 

diabetes screening program. There are 

no costs to respondents other than their 

time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents No. of 

respondents 

No. of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Implementation team members ........................................................................... 10 1 2 20 

Clinic staff ............................................................................................................ 30 1 1 30 

Patients at DDI clinics ......................................................................................... 600 1 20/60 200

Total .............................................................................................................. ........................ ........................ ........................ 250 

Dated: February 22, 2007. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–3333 Filed 2–26–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–07–07AJ] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Joan Karr, CDC 

Acting Reports Clearance Officer, 1600 

Clifton Road, MS–D74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Racial and Ethnic Approaches to 

Community Health across the U.S. 

(REACH US) Management Information 

System (MIS)—New—National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

Racial and Ethnic Approaches to 

Community Health (REACH) currently 

funds forty local coalitions to establish 

community based programs and 

culturally appropriate interventions to 

eliminate racial and ethnic health 

disparities. Communities served by 

REACH include: African American, 

American Indian, Hispanic American, 

Asian American, and Pacific Islander. 

These communities select among infant 

mortality, deficits in breast and cervical 

cancer screening and management, 

cardiovascular diseases, diabetes, HIV/ 

AIDS, and deficits in childhood and 

adult immunizations to focus their 

interventions. Guided by logic models, 

each community articulates goals, 

objectives, and related activities; tracks 

whether goals and objectives are met, 

ongoing, or revised; and evaluates all 

program activities. This information 

will then be entered into the REACH 

Management Information System 

(REACH MIS). REACH MIS is a 

customized internet-based support 

system that allows REACH grantees to 

perform remote data entry and retrieval 

of data. The contract for our current 

Information Network (REACH IN), OMB 


cprice-sewell on PROD1PC62 with NOTICES